CA2116661A1 - Inactivation biochimique des virus a arn - Google Patents
Inactivation biochimique des virus a arnInfo
- Publication number
- CA2116661A1 CA2116661A1 CA002116661A CA2116661A CA2116661A1 CA 2116661 A1 CA2116661 A1 CA 2116661A1 CA 002116661 A CA002116661 A CA 002116661A CA 2116661 A CA2116661 A CA 2116661A CA 2116661 A1 CA2116661 A1 CA 2116661A1
- Authority
- CA
- Canada
- Prior art keywords
- rna
- viruses
- deactivation
- agents
- rnases
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 230000009849 deactivation Effects 0.000 title claims abstract description 8
- 241000700605 Viruses Species 0.000 title description 11
- 241001493065 dsRNA viruses Species 0.000 claims abstract description 23
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 15
- 239000003599 detergent Substances 0.000 claims abstract description 11
- 241001465754 Metazoa Species 0.000 claims abstract description 10
- 102000006382 Ribonucleases Human genes 0.000 claims abstract description 9
- 108010083644 Ribonucleases Proteins 0.000 claims abstract description 9
- 208000015181 infectious disease Diseases 0.000 claims abstract description 6
- 239000011248 coating agent Substances 0.000 claims abstract 2
- 238000000576 coating method Methods 0.000 claims abstract 2
- 238000004659 sterilization and disinfection Methods 0.000 claims description 5
- 238000004140 cleaning Methods 0.000 claims description 4
- 206010028980 Neoplasm Diseases 0.000 claims description 3
- 208000035473 Communicable disease Diseases 0.000 claims 1
- 241000450599 DNA viruses Species 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
- 239000000126 substance Substances 0.000 abstract description 5
- 230000002924 anti-infective effect Effects 0.000 abstract description 4
- 229960005475 antiinfective agent Drugs 0.000 abstract description 3
- 102000004190 Enzymes Human genes 0.000 abstract description 2
- 108090000790 Enzymes Proteins 0.000 abstract description 2
- 241000282414 Homo sapiens Species 0.000 abstract description 2
- 102100035526 B melanoma antigen 1 Human genes 0.000 abstract 1
- 241000196324 Embryophyta Species 0.000 abstract 1
- 101000874316 Homo sapiens B melanoma antigen 1 Proteins 0.000 abstract 1
- 230000000249 desinfective effect Effects 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 210000004877 mucosa Anatomy 0.000 description 4
- 208000030507 AIDS Diseases 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 241000709661 Enterovirus Species 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 241000726306 Irus Species 0.000 description 2
- 201000009906 Meningitis Diseases 0.000 description 2
- 208000000474 Poliomyelitis Diseases 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 206010014599 encephalitis Diseases 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 239000011241 protective layer Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- 206010006187 Breast cancer Diseases 0.000 description 1
- 206010008631 Cholera Diseases 0.000 description 1
- 241000511343 Chondrostoma nasus Species 0.000 description 1
- 208000000655 Distemper Diseases 0.000 description 1
- 235000019227 E-number Nutrition 0.000 description 1
- 239000004243 E-number Substances 0.000 description 1
- 241001466953 Echovirus Species 0.000 description 1
- 241000991587 Enterovirus C Species 0.000 description 1
- 208000000832 Equine Encephalomyelitis Diseases 0.000 description 1
- 241000282324 Felis Species 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 241000713666 Lentivirus Species 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 101710169972 Menin Proteins 0.000 description 1
- 102100030550 Menin Human genes 0.000 description 1
- 241000357437 Mola Species 0.000 description 1
- 241000713869 Moloney murine leukemia virus Species 0.000 description 1
- 241000713333 Mouse mammary tumor virus Species 0.000 description 1
- 208000005647 Mumps Diseases 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- 241000714177 Murine leukemia virus Species 0.000 description 1
- 241000702244 Orthoreovirus Species 0.000 description 1
- 108020002230 Pancreatic Ribonuclease Proteins 0.000 description 1
- 102000005891 Pancreatic ribonuclease Human genes 0.000 description 1
- 208000002606 Paramyxoviridae Infections Diseases 0.000 description 1
- 241000709664 Picornaviridae Species 0.000 description 1
- 108010046983 Ribonuclease T1 Proteins 0.000 description 1
- 208000006257 Rinderpest Diseases 0.000 description 1
- 206010039491 Sarcoma Diseases 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 208000010641 Tooth disease Diseases 0.000 description 1
- 208000010094 Visna Diseases 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 208000014058 canine distemper Diseases 0.000 description 1
- 210000000234 capsid Anatomy 0.000 description 1
- 239000013256 coordination polymer Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000002498 deadly effect Effects 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 201000002491 encephalomyelitis Diseases 0.000 description 1
- 210000004392 genitalia Anatomy 0.000 description 1
- 208000031169 hemorrhagic disease Diseases 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 239000012678 infectious agent Substances 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 208000030194 mouth disease Diseases 0.000 description 1
- 208000010805 mumps infectious disease Diseases 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000011814 protection agent Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 229920002477 rna polymer Polymers 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 229910021653 sulphate ion Inorganic materials 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 241001430294 unidentified retrovirus Species 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/38—Products with no well-defined composition, e.g. natural products
- C11D3/386—Preparations containing enzymes, e.g. protease or amylase
- C11D3/38636—Preparations containing enzymes, e.g. protease or amylase containing enzymes other than protease, amylase, lipase, cellulase, oxidase or reductase
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
- A01N63/50—Isolated enzymes; Isolated proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/66—Enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/48—Medical, disinfecting agents, disinfecting, antibacterial, germicidal or antimicrobial compositions
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Environmental Sciences (AREA)
- Microbiology (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Virology (AREA)
- Agronomy & Crop Science (AREA)
- Dentistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Detergent Compositions (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH1957-92-3 | 1992-06-23 | ||
| CH1957/92A CH682541A5 (de) | 1992-06-23 | 1992-06-23 | Biochemische Inaktivierung von RNA-Viren. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2116661A1 true CA2116661A1 (fr) | 1994-01-06 |
Family
ID=4222554
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002116661A Abandoned CA2116661A1 (fr) | 1992-06-23 | 1992-12-31 | Inactivation biochimique des virus a arn |
Country Status (4)
| Country | Link |
|---|---|
| AU (1) | AU3252693A (fr) |
| CA (1) | CA2116661A1 (fr) |
| CH (1) | CH682541A5 (fr) |
| WO (1) | WO1994000016A1 (fr) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6017046A (en) * | 1998-01-21 | 2000-01-25 | Markovic; Vladimir | Wheelchair apparatus |
| KR100454594B1 (ko) * | 2002-07-22 | 2004-11-03 | 배흥규 | 라이스 커틀릿 및 그 제조방법 |
| DE102004001590B4 (de) * | 2004-01-09 | 2012-12-06 | Gerhard Knapp | Verwendung eines Wirkstoffes und einer Kombination aus Wirkstoffen zur Inhibierung von Milbenkot und/oder Schimmelpilzsporen und/oder Pflanzenpollen und -sporen und/oder zur Denaturierung des Keratins von Tierhaaren |
| KR102501943B1 (ko) | 2014-07-31 | 2023-03-15 | 킴벌리-클라크 월드와이드, 인크. | 유착 방지 조성물 |
| WO2016018475A1 (fr) | 2014-07-31 | 2016-02-04 | Kimberly-Clark Worldwide, Inc. | Composition anti-adhérente |
| KR102441223B1 (ko) | 2014-07-31 | 2022-09-08 | 킴벌리-클라크 월드와이드, 인크. | 유착 방지 알코올계 조성물 |
| WO2016160006A1 (fr) | 2015-04-01 | 2016-10-06 | Kimberly-Clark Worldwide, Inc. | Substrat fibreux pour la capture de bactéries gram négatives |
| GB2562437B (en) | 2016-01-28 | 2022-05-25 | Kimberly Clark Co | Anti-adherent composition against DNA viruses and method of inhibiting the adherence of DNA viruses to a surface |
| US11168287B2 (en) | 2016-05-26 | 2021-11-09 | Kimberly-Clark Worldwide, Inc. | Anti-adherent compositions and methods of inhibiting the adherence of microbes to a surface |
| WO2020070014A1 (fr) * | 2018-10-02 | 2020-04-09 | Novozymes A/S | Composition de nettoyage comprenant un tensioactif anionique et un polypeptide ayant une activité rnase |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR6614M (fr) * | 1967-03-16 | 1969-01-13 | ||
| US3849254A (en) * | 1973-05-31 | 1974-11-19 | Univ Virginia | Process for effecting enzymatic reactions in aerosols |
| IL78703A (en) * | 1985-05-10 | 1993-02-21 | Benzon Alfred | Method of producing extracellular enzymes, the enzymes produced thereby and compositions containing them; a hybrid plasmid and a dna fragment comprising dna encoding the enzymes; a microorganism harbouring the plasmid; and a method for removing nucleic acids from biological materials |
| US5200182A (en) * | 1988-05-26 | 1993-04-06 | Nika Health Products, Ltd. | Antiviral or antibacterial composition and method of use |
| DE3939771A1 (de) * | 1989-12-01 | 1991-06-06 | Behringwerke Ag | Verfahren zur biologischen inaktivierung von nukleinsaeuren |
| DE4016483A1 (de) * | 1990-05-22 | 1991-11-28 | Klinger & Co Dr | Verfahren zur bekaempfung von phytopathogenen viren |
| DE4024530A1 (de) * | 1990-08-02 | 1992-02-06 | Klinger & Co Dr | Verfahren zur bekaempfung von viren |
-
1992
- 1992-06-23 CH CH1957/92A patent/CH682541A5/de not_active IP Right Cessation
- 1992-12-31 AU AU32526/93A patent/AU3252693A/en not_active Abandoned
- 1992-12-31 CA CA002116661A patent/CA2116661A1/fr not_active Abandoned
- 1992-12-31 WO PCT/CH1992/000249 patent/WO1994000016A1/fr not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| AU3252693A (en) | 1994-01-24 |
| CH682541A5 (de) | 1993-10-15 |
| WO1994000016A1 (fr) | 1994-01-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Lowbury et al. | Methods for disinfection of hands and operation sites | |
| US4975217A (en) | Virucidal composition, the method of use and the product therefor | |
| ES2234206T3 (es) | Composicion antimocrobiana. | |
| US4797420A (en) | Disinfectant formulation and method of use | |
| Chaudhary et al. | Fighting the SARS CoV-2 (COVID-19) pandemic with soap | |
| Amgain et al. | Myths versus truths regarding the novel coronavirus disease (COVID-2019) outbreak | |
| US4767788A (en) | Glutaric acid virucidal processes and compositions | |
| YU50598A (sh) | Kompozicija koja sadrži biljku i površinski aktivno sredstvo korisna u proiizvodnji proizvoda za tretiranje herpesa i drugih mikrobnih infekcija | |
| CA2116661A1 (fr) | Inactivation biochimique des virus a arn | |
| AR012237A1 (es) | Composicion de depuracion antimicrobiana enjuagable y metodos para reducir la cantidad de germenes en la piel y para tratar acne. | |
| AR012752A1 (es) | Composicion de depuracion antimicrobiana enjuagable y metodos para reducir la cantidad de germenes en la piel y para tratar acne. | |
| US20070202138A1 (en) | Antimicrobial compositions and method | |
| ES2155114T3 (es) | Composicion limpiadora solida para la piel conteniendo un agente estructurante particular. | |
| JP2001524501A (ja) | 抗菌組成物 | |
| DK566781A (da) | Slibevirksomme midler og deres anvendelse | |
| EP0190797A2 (fr) | Procédé pour exterminer les virus et composition pour sa mise en oeuvre | |
| Miller et al. | Formation of Invisible, Non-perceptible Films on Hands by Cationic Soaps. | |
| JP3655359B2 (ja) | 含水性ソフトコンタクトレンズの洗浄および消毒用組成物 | |
| Ali et al. | Evaluation of laboratory formulated hand sanitizing gel in riyadh municipality central area labs | |
| YU57994A (sh) | Postupak za inaktiviranje virusa u prisustvu polialkilenglikola i farmaceutski preparat dobijen tim postupkom | |
| CN1103367C (zh) | 含有透明质酸钠的消毒洗手液及其制备方法 | |
| CN109906106B (zh) | 化妆品用洗涤剂产品 | |
| EP0263864B1 (fr) | Procede de traitement de surfaces destructeur de micro-organismes | |
| Bawankar et al. | Overview of sanitizer usability in COVID-19 pandemic scenario | |
| JPH01502113A (ja) | 予防の方法およびそのための組成物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued |